Sept 1 (Reuters) - The U.S. Federal Trade Commission (FTC) has allowed Amgen (AMGN.O), opens new tab to continue its $27.8 billion acquisition of Horizon Therapeutics (HZNP.O), opens new tab, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results